Psoriasis is a skin condition involving scaly plaques that can cause itching and pain. Many treatments are available. Switching psoriasis medications should be an informed decision with overall ...

The patient described earlier highlights important clinical points regarding the complex management of psoriasis. First, we must recognize that her obesity, hypertension, dyslipidemia, and non-insulin ...

Major advancements in psoriasis treatments in the past two decades have given people living with the autoimmune condition a wide range of options for controlling symptoms. There are more than a dozen ...

Psoriasis is a chronic T-lymphocyte-mediated inflammatory disorder that affects 2–3% of the population globally. It is associated with abnormal keratinocyte proliferation, and is clinically ...

Finding an effective treatment for psoriatic disease (PD) often requires trial and error. Because people experience PD differently, there's no one-size-fits-all ...

Topical or oral corticosteroids generally cost $10 to $20 a month.

Treatment costs have increased for patients with plaque psoriasis who take biologic medications. Patients can save financially if they and their physicians seek out lower-cost options before opting ...

A UCB drug with a novel approach to plaque psoriasis won a long-awaited FDA approval, positioning it to bring patients a new choice in a crowded market of products for the prevalent skin condition.

Please provide your email address to receive an email when new articles are posted on . WHO added adalimumab and ustekinumab for moderate to severe psoriasis to its Essential Medicines List. The ...

Only three of 13 biologics used to treat psoriasis were found cost-effective in the US market, according to a new analysis that used an approach to weighing pharmaceutical prices and benefits already ...

Conventional systemic therapies. Conventional systemic therapies used for psoriasis treatment include acitretin, methotrexate, and cyclosporine, which have been used for more than 10 years. 2,13 The ...